Concepedia

Hans‐Peter Vornlocher

HV

Statistics

Publications

38

Citations

6.2K

H-Index

32

Active since

1997

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Max Planck Institute for Biophysical Chemistry

University of California, Davis

Medizinische Hochschule Hannover

Massachusetts Institute of Technology

Hans‐Peter Vornlocher is an author at Alnylam Pharmaceuticals (United States) specializing in molecular biology, life sciences, and rna interference.

Publications per year

1997–2020

38

Publications

38

RNAi-mediated gene silencing in non-human primates

Tracy Zimmermann, Amy C. H. Lee, Akin Akinc et al. · Nature · 2006 · 1.3K citations

, , +8

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Akin Akinc, Andreas Zumbuehl, Michael S. Goldberg et al. · Nature Biotechnology · 2008 · 1.2K citations

, , +16

Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells

Christina Lorenz, Philipp Hadwiger, Matthias John et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 334 citations

, , +17

Protein composition of human prespliceosomes isolated by a tobramycin affinity-selection method

Klaus Hartmuth, Henning Urlaub, Hans‐Peter Vornlocher et al. · Proceedings of the National Academy of Sciences · 2002 · 303 citations · Full text

, , +16

c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis

Stephan Mathas, Andreas Lietz, Ioannis Anagnostopoulos et al. · The Journal of Experimental Medicine · 2004 · 200 citations · Full text

, , +17

1–5 of 38